Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,135
Price
$21.39
Total Value
$45.67K
Shares Held After
639,140
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,136
Price
$21.39
Total Value
$45.69K
Shares Held After
639,141
% of Holdings
0.3%
Centessa Pharmaceuticals plc (CNTA)
HUSSAIN IQBAL J — Chief Legal Officer
Shares
1,010
Price
$25.01
Total Value
$25.26K
Shares Held After
104,376
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
5,296
Price
$82.96
Total Value
$439.36K
Shares Held After
45,413
% of Holdings
10.4%
IONIS PHARMACEUTICALS INC (IONS)
Birchler Brian — EVP, Corp and Development Ops
Shares
6,179
Price
$83.03
Total Value
$513.05K
Shares Held After
66,247
% of Holdings
8.5%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
6,179
Price
$83.53
Total Value
$516.15K
Shares Held After
71,983
% of Holdings
7.9%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
6,988
Price
$83.24
Total Value
$581.70K
Shares Held After
132,881
% of Holdings
5.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
5,885
Price
$82.95
Total Value
$488.14K
Shares Held After
100,293
% of Holdings
5.5%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
6,179
Price
$83.45
Total Value
$515.63K
Shares Held After
69,702
% of Holdings
8.1%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
6,179
Price
$82.93
Total Value
$512.45K
Shares Held After
47,747
% of Holdings
11.5%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
62,970
Price
$82.72
Total Value
$5.21M
Shares Held After
283,927
% of Holdings
18.2%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$41.09
Total Value
$821.81K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,686
Price
$4.13
Total Value
$23.48K
Shares Held After
559,359
% of Holdings
1.0%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Quartel Adrian W — Chief Medical Officer
Shares
4,533
Price
$8.83
Total Value
$40.04K
Shares Held After
9,723
% of Holdings
31.8%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Schafer Joshua — CCO
Shares
3,375
Price
$8.83
Total Value
$29.80K
Shares Held After
37,444
% of Holdings
8.3%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal & Compliance
Shares
4,080
Price
$8.83
Total Value
$36.01K
Shares Held After
49,919
% of Holdings
7.6%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Sangiovanni Timothy J. — SVP, Finance & Corp Controller
Shares
1,750
Price
$8.82
Total Value
$15.44K
Shares Held After
20,924
% of Holdings
7.7%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
2,906
Price
$29.00
Total Value
$84.27K
Shares Held After
986,667
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
22,094
Price
$28.27
Total Value
$624.67K
Shares Held After
989,573
% of Holdings
2.2%
Aprea Therapeutics, Inc. (APRE)
Hamill John P. — SrVP/CFO/Prin Fin & Acct Ofcr
Shares
5,700
Price
$0.89
Total Value
$5.07K
Shares Held After
33,433
% of Holdings
17.0%
Aprea Therapeutics, Inc. (APRE)
Gilad Oren — Director
Shares
28,100
Price
$0.89
Total Value
$25.01K
Shares Held After
373,720
% of Holdings
7.5%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
6,612
Price
$18.11
Total Value
$119.74K
Shares Held After
365,273
% of Holdings
1.8%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
98
Price
$17.37
Total Value
$1.70K
Shares Held After
83,672
% of Holdings
0.1%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
4,797
Price
$16.58
Total Value
$79.55K
Shares Held After
83,770
% of Holdings
5.4%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
73
Price
$17.37
Total Value
$1.27K
Shares Held After
45,427
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
3,588
Price
$16.58
Total Value
$59.50K
Shares Held After
45,500
% of Holdings
7.3%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
88
Price
$17.37
Total Value
$1.53K
Shares Held After
57,010
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
4,333
Price
$16.58
Total Value
$71.85K
Shares Held After
57,098
% of Holdings
7.1%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
15,284
Price
$4.32
Total Value
$66.03K
Shares Held After
565,045
% of Holdings
2.6%
DBV Technologies S.A. (DBVT)
Mohideen Pharis — Chief Medical Officer
Shares
534
Price
$4.86
Total Value
$2.60K
Shares Held After
144,995
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
63
Price
$103.39
Total Value
$6.51K
Shares Held After
58,117
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,819
Price
$102.67
Total Value
$186.76K
Shares Held After
58,180
% of Holdings
3.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
3,429
Price
$101.80
Total Value
$349.07K
Shares Held After
59,999
% of Holdings
5.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
189
Price
$100.95
Total Value
$19.08K
Shares Held After
63,428
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
8,667
Price
$29.74
Total Value
$257.78K
Shares Held After
986,667
% of Holdings
0.9%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
16,333
Price
$29.19
Total Value
$476.80K
Shares Held After
995,334
% of Holdings
1.6%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
2,800
Price
$45.01
Total Value
$126.02K
Shares Held After
10,503
% of Holdings
21.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,500
Price
$44.04
Total Value
$154.15K
Shares Held After
13,303
% of Holdings
20.8%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
1,200
Price
$43.18
Total Value
$51.82K
Shares Held After
16,803
% of Holdings
6.7%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
21,262
Price
$18.55
Total Value
$394.41K
Shares Held After
371,885
% of Holdings
5.4%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
664
Price
$19.05
Total Value
$12.65K
Shares Held After
393,147
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
5,860
Price
$18.61
Total Value
$109.05K
Shares Held After
393,811
% of Holdings
1.5%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
811
Price
$14.48
Total Value
$11.75K
Shares Held After
0
% of Holdings
100.0%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
2,800
Price
$14.09
Total Value
$39.44K
Shares Held After
811
% of Holdings
77.5%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
191
Price
$6.59
Total Value
$1.26K
Shares Held After
17,476
% of Holdings
1.1%
Ainos, Inc. (AIMD)
Taiwan Carbon Nano Technology Corp — 10% Owner
Shares
46,000
Price
$2.17
Total Value
$99.81K
Shares Held After
989,925
% of Holdings
4.4%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
50
Price
$7.03
Total Value
$351.50
Shares Held After
22,622
% of Holdings
0.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
32,612
Price
$31.80
Total Value
$1.04M
Shares Held After
24,353
% of Holdings
57.2%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,695
Price
$8.45
Total Value
$14.32K
Shares Held After
249,301
% of Holdings
0.7%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,686
Price
$8.45
Total Value
$22.70K
Shares Held After
420,047
% of Holdings
0.6%
Showing 1–50 of 1179 transactions (page 1 of 24)